Photothermally enhanced antibacterial wound healing using albumin-loaded tanshinone IIA and IR780 nanoparticles
Chronic and infected wounds, particularly those caused by bacterial infections, present significant challenges in medical treatment. This study aimed to develop a novel nanoparticle formulation to enhance wound healing by combining antimicrobial and photothermal therapy using albumin as a carrier for Tanshinone IIA and the near-infrared photothermal agent IR780. The nanoparticles were synthesized to exploit the antimicrobial effects of Tanshinone IIA and the photothermal properties of IR780 when exposed to near-infrared laser irradiation. Characterization of the nanoparticles was performed using Transmission Electron Microscopy (TEM) and spectroscopic analysis to confirm their successful synthesis. <i>In vitro</i> antibacterial activity was evaluated using cultures of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), and <i>in vivo</i> efficacy was tested in a mouse model of MRSA-infected wounds. Wound healing progression was assessed over 16 days, with statistical analysis performed using two-way ANOVA followed by Tukey's post-hoc test. The nanoparticles demonstrated significant photothermal properties, enhancing bacterial eradication and promoting the controlled release of Tanshinone IIA. <i>In vitro</i> studies showed superior antibacterial activity, especially under photothermal activation, leading to a substantial reduction in bacterial viability in MRSA cultures. In vivo, nanoparticle treatment combined with near-infrared laser irradiation significantly improved wound closure rates compared to controls and treatments without photothermal activation. By the 16th day post-treatment, significant improvements in wound healing were observed, highlighting the potential of the combined photothermal and pharmacological approach. These findings suggest that albumin-loaded nanoparticles containing Tanshinone IIA and IR780, activated by near-infrared light, could offer an effective therapeutic strategy for managing chronic and infected wounds, promoting both infection control and tissue repair.
Authors
- Kaikai Wang (ORCID: https://orcid.org/0000-0002-1838-4394)
- Yimei Li (ORCID: https://orcid.org/0000-0001-9067-6992)
- Chaoqun Ma (ORCID: https://orcid.org/0000-0001-5387-7357)
- Haidong Chen (ORCID: https://orcid.org/0000-0001-6476-5748)
- Dexuan Chen (ORCID: https://orcid.org/0000-0001-6596-8184)
- Yong Fang (ORCID: https://orcid.org/0000-0002-0588-2116)
- Xianliang Gong
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nantong University (CN)
- Jiangsu Province Hospital (CN)
Publication Details
- Journal
- Frontiers in Bioengineering and Biotechnology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.3389/fbioe.2024.1487660
- Citations
- 11
- Primary Topic
- Wound Healing and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.75
Funders
- Nanjing University of Chinese Medicine
- Nanjing University